Development · 1 Oct 2026
2 publishers have reported this development. Each act of reporting is below, cited.
Anupam Rasayan India has completed the acquisition of a 48.2% controlling stake in Bliss GVS Pharma at ₹299 per share.
Anupam Rasayan India has paid the consideration towards the transaction of a 48.2 per cent controlling stake in Bliss GVS Pharma Limited at ₹299 per share.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.